🇺🇸 FDA
Patent

US 7718684

Methods and materials for assessing prostate cancer therapies and compounds

granted A61KA61K31/426

Quick answer

US patent 7718684 (Methods and materials for assessing prostate cancer therapies and compounds) held by The Regents of the University of California expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K31/426